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To the Editor,
In their review of live attenuated influenza vaccine (LAIV), Esposito et al. stated that in the US and Europe, LAIV is not recom-
mended for children and adults with asthma and children younger than 5 years of age with a history of recurrent wheezing.1  While 
this statement is accurate for the US, it is not accurate for the European Union. The European Medicines Agency approved LAIV for 
use in children and adolescents 24 months to younger than 18 years of age, with a warning against use in children and adolescents 
with severe asthma or active wheezing because these individuals have not been adequately studied in clinical studies.2  However, based 
on studies that have been conducted, in the European Union there is no warning against LAIV use in children and adolescents with 
mild to moderate asthma or a history of recurrent wheezing.2 In the European Union, LAIV is not approved for use in adults 18 years 
of age and older.
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